Drug Addiction Treatment Act - PDFSEARCH.IO - Document Search Engine

Drug Addiction Treatment Act
Results: 275

#	Item
251	Initial REMS Approval: December[removed]NDA[removed]SUBUTEX® (buprenorphine) sublingual tablet CIII Buprenorphine (opioid partial agonist-antagonist) Add to Reading List Source URL: www.fda.gov Language: English Drug rehabilitation Dosage forms Substance dependence Morphinans Buprenorphine Opioid dependence Drug Addiction Treatment Act Methadone Reckitt Benckiser Chemistry Pharmacology Medicine
252	SUBOXONE® (buprenorphine and naloxone) sublingual film CIII Buprenorphine (opioid partial agonist‐antagonist) Naloxone (opioid antagonist) Add to Reading List Source URL: www.fda.gov Language: English Morphinans Drug rehabilitation Ketones Substance dependence Buprenorphine Naloxone Opioid dependence Drug Addiction Treatment Act Methadone Chemistry Organic chemistry Alcohols
253	Initial REMS Approval: December[removed]NDA[removed]SUBOXONE (buprenorphine and naloxone) sublingual tablet CIII Add to Reading List Source URL: www.fda.gov Language: English Alcohols Morphinans Drug rehabilitation Ketones Dosage forms Buprenorphine Naloxone Opioid dependence Drug Addiction Treatment Act Chemistry Organic chemistry Pharmacology
254	Medical Board of California Newslet te r A Quarterly Publication Add to Reading List Source URL: mbc.ca.gov Language: English - Date: 2014-07-01 14:58:54 Pharmaceuticals policy Drugs Health informatics Clinical pharmacology Medical prescription Pain management Prescription medication Pharmacy Drug Addiction Treatment Act Medicine Health Pharmacology
255	Medical Board of California Newslet te r A Quarterly Publication Add to Reading List Source URL: www.mbc.ca.gov Language: English - Date: 2014-07-01 14:58:54 Pharmaceuticals policy Drugs Health informatics Clinical pharmacology Medical prescription Pain management Prescription medication Pharmacy Drug Addiction Treatment Act Medicine Health Pharmacology
256	DEA REGISTRATION RECORD LAYOUT DEA REGISTRATION RECORD LAYOUT DEA REGISTRATION RECORD LAYOUT Add to Reading List Source URL: www.ntis.gov Language: English - Date: 2014-03-12 14:16:30 Controlled Substances Act Drug Addiction Treatment Act Regular expression Software engineering Government Theoretical computer science DEA number Identifiers Drug Enforcement Administration
257	s.c. department of alcohol and other drug abuse services The big Issue VOLUME 32, ISSUE 2 APRIL-JUNE 2014 Add to Reading List Source URL: www.daodas.state.sc.us Language: English - Date: 2014-06-30 10:45:23 Pharmaceutical sciences Health Food and Drug Administration Therapeutics United States Public Health Service Drug rehabilitation Controlled Substances Act Alcoholism Center for Substance Abuse Treatment Substance abuse Drug addiction Pharmacology
258	VERMONT BUPRENORPHINE PRACTICE GUIDELINES January 1, 2010 CONTENTS Page Introduction Add to Reading List Source URL: healthvermont.gov Language: English - Date: 2011-07-21 15:56:40 Morphinans Ethers Phenols Drug rehabilitation Buprenorphine Drug Addiction Treatment Act Opioid dependence Opioid replacement therapy Methadone Chemistry Organic chemistry Alcohols
259	VERMONT BUPRENORPHINE PRACTICE GUIDELINES January 1, 2010 CONTENTS Page Introduction Add to Reading List Source URL: www.healthvermont.gov Language: English - Date: 2011-07-21 15:56:40 Morphinans Ethers Phenols Drug rehabilitation Buprenorphine Drug Addiction Treatment Act Opioid dependence Opioid replacement therapy Methadone Chemistry Organic chemistry Alcohols
260	Vermont Board of Medical Practice Policy on DATA 2000 and Treatment of Opioid Addiction in the Medical Office Background and Introduction The Vermont Board of Medical Practice (the Board) is committed to protecting the Add to Reading List Source URL: www.healthvermont.gov Language: English - Date: 2014-06-06 11:52:45 Alcohols Ketones Drug rehabilitation Phenols Drug Addiction Treatment Act Buprenorphine Opioid dependence Methadone Naltrexone Chemistry Organic chemistry Morphinans